These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 16251126
41. Effect of platelet-activating factor, lyso-platelet-activating factor, and lysophosphatidylcholine on sperm motion: importance of albumin for motility stimulation. Jarvi K, Roberts KD, Langlais J, Gagnon C. Fertil Steril; 1993 Jun; 59(6):1266-75. PubMed ID: 8495776 [Abstract] [Full Text] [Related]
42. Determination of platelet-activating factor and alkyl-ether phospholipids by gas chromatography-mass spectrometry via direct derivatization. Balazy M, Braquet P, Bazan NG. Anal Biochem; 1991 Jul; 196(1):1-10. PubMed ID: 1888023 [Abstract] [Full Text] [Related]
43. Presence and metabolism of lyso platelet-activating factor in human bone marrow. Denizot Y, Rougier F, Dupuis F, Trimoreau F, Dulery C, Laskar M, Praloran V. J Lipid Mediat Cell Signal; 1997 May; 16(1):53-62. PubMed ID: 9101422 [Abstract] [Full Text] [Related]
44. Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure. Detopoulou P, Nomikos T, Fragopoulou E, Antonopoulou S, Kotroyiannis I, Vassiliadou C, Panagiotakos DB, Chrysohoou C, Pitsavos C, Stefanadis C. Clin Biochem; 2009 Jan; 42(1-2):44-9. PubMed ID: 18955040 [Abstract] [Full Text] [Related]
45. Tear film lipid layer alterations in allergic conjunctivitis. Suzuki S, Goto E, Dogru M, Asano-Kato N, Matsumoto Y, Hara Y, Fujishima H, Tsubota K. Cornea; 2006 Apr; 25(3):277-80. PubMed ID: 16633026 [Abstract] [Full Text] [Related]
46. Antiangiogenic activity in tears: presence of pigment-epithelium-derived factor. New insights and preliminary results. Abdiu O, Van Setten G. Ophthalmic Res; 2008 Apr; 40(1):16-8. PubMed ID: 18032913 [Abstract] [Full Text] [Related]
47. Development of a high-performance liquid chromatographic-mass spectrometric technique, with an ionspray interface, for the determination of platelet-activating factor (PAF) and lyso-PAF in biological samples. Silvestro L, Da Col R, Scappaticci E, Libertucci D, Biancone L, Camussi G. J Chromatogr; 1993 Sep 24; 647(2):261-9. PubMed ID: 8227267 [Abstract] [Full Text] [Related]
48. Platelet activating factor, lyso-platelet activating factor and arachidonic acid release in normal human skin and the influence of topical steroid treatment. Barr RM, Lawlor F, Judge MR, Courtney P, Barlow R, Kobza Black A, Mallet AI, Greaves MW. Br J Clin Pharmacol; 1993 Jun 24; 35(6):637-41. PubMed ID: 8329291 [Abstract] [Full Text] [Related]
49. Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis. Callea L, Arese M, Orlandini A, Bargnani C, Priori A, Bussolino F. J Neuroimmunol; 1999 Feb 01; 94(1-2):212-21. PubMed ID: 10376955 [Abstract] [Full Text] [Related]
50. Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. Leonardi A, Sathe S, Bortolotti M, Beaton A, Sack R. Allergy; 2009 May 01; 64(5):710-7. PubMed ID: 19220217 [Abstract] [Full Text] [Related]
51. Actions of platelet activating factor (PAF) homologues and their combinations on neutrophil chemokinesis and cutaneous inflammatory responses in man. Archer CB, Cunningham FM, Greaves MW. J Invest Dermatol; 1988 Jul 01; 91(1):82-5. PubMed ID: 3385217 [Abstract] [Full Text] [Related]
52. Platelet activating factor (PAF) and lyso-PAF in psoriasis. Judge MR, Barr RM, Mallet AI, Courtney F, Kobza Black A, Greaves MW. Arch Dermatol Res; 1994 Jul 01; 286(7):376-9. PubMed ID: 7818279 [Abstract] [Full Text] [Related]
53. Substance P and its metabolites in normal human tears. Yamada M, Ogata M, Kawai M, Mashima Y, Nishida T. Invest Ophthalmol Vis Sci; 2002 Aug 01; 43(8):2622-5. PubMed ID: 12147594 [Abstract] [Full Text] [Related]
54. [Generation of platelet activating factor by neutrophils in patients with pulmonary tuberculosis]. Aladysheva ZhI, Kaminskaia GO. Probl Tuberk; 1995 Aug 01; (2):20-3. PubMed ID: 7777455 [Abstract] [Full Text] [Related]
55. Quantitation of lyso-platelet activating factor molecular species from human neutrophils by mass spectrometry. Haroldsen PE, Clay KL, Murphy RC. J Lipid Res; 1987 Jan 01; 28(1):42-9. PubMed ID: 3104521 [Abstract] [Full Text] [Related]
56. Elevated levels of human alpha -defensin in tears of patients with allergic conjunctival disease complicated by corneal lesions: detection by SELDI ProteinChip system and quantification. Hida RY, Ohashi Y, Takano Y, Dogru M, Goto E, Fujishima H, Saito I, Saito K, Fukase Y, Tsubota K. Curr Eye Res; 2005 Sep 01; 30(9):723-30. PubMed ID: 16123017 [Abstract] [Full Text] [Related]
57. Platelet activating factor and its metabolite promote sleep in rabbits. Kushikata T, Fang J, Krueger JM. Neurosci Lett; 2006 Feb 20; 394(3):233-8. PubMed ID: 16263215 [Abstract] [Full Text] [Related]
58. Periodontal parameters and platelet-activating factor levels in serum and gingival crevicular fluid in a Chinese population. Zheng P, Chen H, Shi S, Jepsen S, Eberhard J. J Clin Periodontol; 2006 Nov 20; 33(11):797-802. PubMed ID: 16970624 [Abstract] [Full Text] [Related]
59. Platelet-activating factor in the inflammatory exudate in the anaphylactic phase of allergic inflammation in rats. Watanabe M, Ohuchi K, Sugidachi A, Hirasawa N, Hayashi Y, Tsurufuji S. Int Arch Allergy Appl Immunol; 1987 Nov 20; 84(4):396-403. PubMed ID: 3119503 [Abstract] [Full Text] [Related]
60. Quantification of distinct molecular species of the 2-lyso metabolite of platelet-activating factor by gas chromatography-negative-ion chemical ionization mass spectrometry. Turk J, Bohrer A, Stump WT, Ramanadham S, Mangino MJ. J Chromatogr; 1992 Mar 27; 575(2):183-96. PubMed ID: 1629294 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]